HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacologic inhibition of IκB kinase activates immediate hypersensitivity reactions in mice.

Abstract
Pharmacologic inhibitors of IκB kinase (IKK), especially IKK-β, have been developed to treat inflammatory diseases. However, their interactions with components of the NF-κB pathways are not fully known in allergic diseases. To examine whether IKK is involved in immediate hypersensitivity reactions and to determine whether counterregulatory mechanisms in the NF-κB activation system were active, we examined the role played by IKK components on mast cell degranulation using a murine ocular immediate hypersensitivity reaction model. Pharmacologic inhibition of IKK in mice caused paradoxical aggravation of the mast cell-mediated immediate hypersensitivity reaction and up-regulation in the expression of inflammatory cytokines. Downstream analyses showed that B-cell deficiency or treatment by IL-1 receptor antagonist corrected the aberrant activation of tissue-resident mast cells, which would indicate contribution by activated B cells. Analyses of co-cultures of tissue-resident mast cells showed the contribution of activated B cells to activation of mast cells and secretion of inflammatory cytokines. Aberrant activation of the NF-κB promoter in isolated B cells was induced exclusively by IKK-β inhibition and was negated by ablating IKK-α. Aggravated mast cell degranulation by pharmacologic IKK inhibition in the murine immediate hypersensitivity reaction was corrected by B-cell-targeted inhibition of IKK-α. Thus, IKK-β limits B-cell-mediated mast cell activation and inflammatory cytokine induction in immediate hypersensitivity by counterbalancing the activity of IKK-α.
AuthorsDai Miyazaki, Sachiko Mihara, Koudai Inata, Shin-ichi Sasaki, Takeshi Tominaga, Keiko Yakura, Waka Ishida, Atsuki Fukushima, Yoshitsugu Inoue
JournalThe American journal of pathology (Am J Pathol) Vol. 183 Issue 1 Pg. 96-107 (Jul 2013) ISSN: 1525-2191 [Electronic] United States
PMID23665348 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antigens, Plant
  • Biomarkers
  • Cytokines
  • NF-kappa B
  • Plant Extracts
  • Protein Kinase Inhibitors
  • ragweed pollen
  • Chuk protein, mouse
  • I-kappa B Kinase
  • Ikbkb protein, mouse
  • beta-N-Acetylhexosaminidases
Topics
  • Animals
  • Antigens, Plant (administration & dosage, adverse effects)
  • B-Lymphocytes (drug effects, enzymology)
  • Biomarkers (metabolism)
  • Blotting, Western
  • Conjunctivitis, Allergic (enzymology, etiology, immunology)
  • Cytokines (metabolism)
  • Enzyme-Linked Immunosorbent Assay
  • I-kappa B Kinase (antagonists & inhibitors, metabolism)
  • Mast Cells (drug effects, enzymology)
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B (metabolism)
  • Plant Extracts (administration & dosage, adverse effects)
  • Protein Kinase Inhibitors (administration & dosage, pharmacology)
  • Real-Time Polymerase Chain Reaction
  • beta-N-Acetylhexosaminidases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: